New Therapeutic System of Ruptured Intracranial Aneurysms Based on Big Data From Chinese Population

NCT03153748 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2017-05-15

No results posted yet for this study

Summary

This study aims at clarifying the current situation of Emergency treatment of aneurysmal subarachnoid hemorrhage (SAH) in China, and analyzing the safety and efficacy of the treatment strategy between interventional treatment and open surgery, so as to improve the diagnosis and treatment of aneurysmal SAH.

Conditions

  • Subarachnoid Hemorrhage, Aneurysmal

Sponsors & Collaborators

  • Changhai Hospital

    lead OTHER

Principal Investigators

  • Qinghai Huang, MD · Changhai Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03153748 on ClinicalTrials.gov